Induction chemotherapy (IC) with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing concomitant chemoradiotherapy (CRT) in fit patients with locally advanced head and neck cancer (LAHNC): The CONDOR study-A study of the Dutch Head and Neck Society

被引：0
|
作者：
Driessen, Chantal
De Boer, J. P.
Gelderblom, Hans
Rasch, Coen R. N.
de Jong, Martin
Verbist, Berit M.
Tesselaar, Margot Et
Van der Graaf, Winette T. A.
Kaanders, J. H.
Van Herpen, Carla M. L. -
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Radiat Oncol, Leiden, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands
[6] Leiden Univ, Med Ctr, Leiden, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6057
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, H
    Tsukuda, M
    Mochimatu, I
    Ishitoya, J
    Kawai, S
    Mikami, Y
    Matsuda, H
    Tanigaki, Y
    Horiuchi, C
    Ikeda, Y
    Taguchi, T
    Ono, M
    Yoshida, T
    Hirose, S
    Sakuma, Y
    Yamamoto, K
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 348 - 352
  • [42] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    H Katori
    M Tsukuda
    I Mochimatu
    J Ishitoya
    S Kawai
    Y Mikami
    H Matsuda
    Y Tanigaki
    C Horiuchi
    Y Ikeda
    T Taguchi
    M Ono
    T Yoshida
    S Hirose
    Y Sakuma
    K Yamamoto
    British Journal of Cancer, 2004, 90 : 348 - 352
  • [43] Preliminary report of induction chemotherapy with Docetaxel, Cisplatin, 5FU (TPF) in the treatment of locally advanced Head and Neck cancer
    Kehagioglou, P.
    Ioannidou, G.
    Xesfyngi, D.
    Lagogiannis, G.
    Stavrinidis, I.
    Papala, K.
    Papadogiorgakis, N.
    Katsilieris, I.
    ONKOLOGIE, 2010, 33 : 127 - 127
  • [44] The Efficacy of Induction Chemotherapy with Docetaxel, Cisplatin and 5-fluorouracil Combined with Cisplatin Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Matched Pair Analysis
    Teo, M.
    Karakaya, E.
    Young, C. A.
    Dyker, K. E.
    Coyle, C.
    Sen, M.
    Prestwich, R. J. D.
    CLINICAL ONCOLOGY, 2013, 25 (11) : 647 - 653
  • [45] The role of neck dissection (ND) after neoadjuvant chemotherapy (CT) with docetaxel, cisplatin and 5-fluorouracil (TPF) followed by concomitant chemoradiation (CR) with cisplatin for patients with locoregionally advanced squamous cell carcinomas of the head and neck (SCCHN)
    da Silva, I. Pires
    Mouta, J.
    Winckler, P.
    Costa, D.
    Netto, E.
    Santos, J. Rosa
    Magalhaes, M.
    Alexandre, T.
    Sargento, I.
    Ferreira, M.
    Moreira, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S563 - S564
  • [46] Nimotuzumab plus chemotherapy with docetaxel, cisplatin, 5-fluorouracil for locally advanced head and neck squamous cell carcinoma: A clinical study
    Wang, Xing
    Gu, Jianmin
    Shao, Cuiling
    Han, Kun
    Meng, Jian
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (02) : 312 - 316
  • [47] A prospective comparative study on biweekly docetaxel, cisplatin, 5-fluorouracil, leucovorin (TPFL) versus triweekly TPF as an induction chemotherapy in locally advanced squamous cell carcinoma of head and neck
    Anantharamu, S.
    Jacob, L. A.
    Dasappa, L.
    Babu, M. C. Suresh
    Lokesh, K. N.
    Rudresha, A. H.
    Krishnappa, R. Lakkavalli
    Saldanha, S. C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S850 - S850
  • [48] A retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced head and neck cancer
    Kim, Brian
    Dillman, Robert O.
    Chen, Peter
    Hafer, Russell
    Cox, Craig
    Barth, Neil
    Carroll, Matthew
    VanderMolen, Louis
    Nguyen, Minh
    Huang, JinChu
    Minion, Annamarie
    Plunkett, Marianne
    Mackintosh, Ralph
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (01) : 93 - 97
  • [49] Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment
    Haddad, R
    Tishler, RB
    Norris, CM
    Mahadevan, A
    Busse, P
    Wirth, L
    Goguen, LA
    Sullivan, CA
    Costello, R
    Case, MA
    Posner, MR
    ONCOLOGIST, 2003, 8 (01): : 35 - 44
  • [50] Induction and concomitant chemoradiotherapy (CCRT) using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with stage IVB advanced head and neck cancer
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawa, Shin-ichi
    Tuchida, Kodai
    Kusaka, Takahiro
    Ohashi, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345